Chinese
Home
About Livzon
Milestones
Leaders' Caring
Company Honors
Cultural Vision
Contact Us
Media
Livzon News
Employment system
Investor Relations
Company Governance
Announcement
Financial Reports
ESG Report
Shareholder Returns
Stock Information
Sustainable Development
Human Development
Board Diversity Policy
Business Ethics
Supplier
Environment, Occupational Health and Safety (EHS)
Philanthropy
Privacy Policy
Tax policy
ESG Ratings and Honors
Product
Leading Products
Products List
ADR Reporting
R&D
R&D Platforms
Livzon microspheres
Livzon Bio
Livzon Research Institute
R&D Achievements
IP Achievements
Overseas Market
Overseas Business
Specialty Products
Certificates
Contact us
Join Us
Social Recruitment
Campus Recruitment
Compensation and Benefits
Appeal Against
Bidding procurement
Tender Announcement
Supplier Login
Supervision and Reporting
Contact information
Online message
Labor System
New Lijuzhu Magazine
Three honors witness the high-quality development of LIZHU.
2023-02-23
Yuan Lin, the director of the Drug Regulation Department of the National Medical Products Administration, and his team visited Lijuzhou Group for inspection and research.
2023-02-22
Zhao Junning, Deputy Director of the National Medical Products Administration, and his team visited Lijuzhu Group for inspection and research.
2023-02-19
The COVID-19 severe treatment drug, Lianhua Qingwen, has been approved.
2023-01-31
Employee Complaint Management System
1. In order to safeguard the legitimate rights and interests of the employees of Livzon Pharmaceutical Group Inc. (hereinafter referred to as "the Company" or "Headquarters") and its subsidiaries (hereinafter referred to as "Livzon Group" or "the Group"), to provide a formal and confidential reporting channel for employee complaints, and to standardize the handling of complaints and related work, this system is specially formulated. 2. This system applies to complaints related to HR and the "Livzon Group Labor Employment and Code of Conduct" (hereinafter referred to as "the Code"). 3. This system covers all formal employees, labor dispatch personnel, outsourced personnel, part-time personnel, interns, and other individuals who have established labor relations with Livzon Group. 4. Each subsidiary of the Company shall formulate its own employee complaint system in accordance with this system and implement it.
2022-12-16
LIZHU Biotech's recombinant COVID-19 fusion protein (CHO cell) vaccine has been selected for the "Implementation Plan for the Second Dose Booster Immunization of COVID-19 Vaccine".
The "Red Mentor" passes on knowledge and helps others, carrying forward the spirit of hard work.
2022-11-28
Lizhu was selected for the 2022 Top 20 ESG Competitiveness of Chinese Pharmaceutical Listed Companies and the Top 10 Wind ESG Rating Industry List.
